Invertebral Disc Disease
Symptoms, Doctors, Treatments, Advances & More

Invertebral Disc Disease Overview

Save information for later
Sign Up

Learn About Invertebral Disc Disease

What is the definition of Invertebral Disc Disease?
Intervertebral disc disease, also known as degenerative disc disease, is a condition in which the one or more of the discs that cushion and absorb pressure between the vertebrae of the spine degenerate and cause pain. Intervertebral disc disease may lead to curvature of the spine (adult scoliosis), herniated disc, spinal stenosis (narrowing), and slipped discs (spondylolisthesis). Intervertebral disc disease is a part of aging and is common in older adults.
What are the symptoms of Invertebral Disc Disease?
Symptoms of intervertebral disc disease depend on the type and affected discs. The most common symptom of intervertebral disc disease is periodic or chronic pain in the neck or back. The pain may increase when bending, twisting the body, sitting, or lifting. Herniated intervertebral discs can press on the spinal nerves and cause pain that runs down the leg (sciatica), weakness, and numbness in the back or legs. Degenerated intervertebral discs may also cause the growth of bone spurs (osteophytes) at their edges that pinch the spinal nerves, causing weakness, numbness, difficulty walking, and bladder and bowel control problems. A completely degenerated intervertebral disc may cause permanent nerve damage and impaired movement.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Invertebral Disc Disease?
Treatment for intervertebral disc disease includes medications, such as acetaminophen or non-steroidal anti-inflammatory drugs; arthritis medications; hot and cold therapy; stretching; physical therapy; exercise; oral cortisone; cortisone injections; radiofrequency neurotomy; or spinal decompression surgery, such as discectomy, foraminotomy, laminectomy, bone spur (osteophyte) removal; and spinal fusion.
Who are the top Invertebral Disc Disease Local Doctors?
Arash Emami
Elite in Invertebral Disc Disease
Dr. Arash Emami
Orthopedics
Elite in Invertebral Disc Disease
Dr. Arash Emami
Orthopedics

University Place Orthopaedics

95 University Place, Floor 8, 
New York, NY 
212-604-1360
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arash Emami is an Orthopedics provider in New York, New York. Dr. Emami is rated as an Elite provider by MediFind in the treatment of Invertebral Disc Disease. His top areas of expertise are Invertebral Disc Disease, Spinal Stenosis, Scoliosis, Spinal Fusion, and Laminectomy. Dr. Emami is currently accepting new patients.

Kumar G. Sinha
Elite in Invertebral Disc Disease
Dr. Kumar G. Sinha
Orthopedics
Elite in Invertebral Disc Disease
Dr. Kumar G. Sinha
Orthopedics

University Spine Center

504 Valley Road, 
Wayne, NJ 
973-686-0700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kumar Sinha is an Orthopedics provider in Wayne, New Jersey. Dr. Sinha is rated as an Elite provider by MediFind in the treatment of Invertebral Disc Disease. His top areas of expertise are Invertebral Disc Disease, Spinal Stenosis, Spondylolisthesis, Spinal Fusion, and Laminectomy. Dr. Sinha is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Subodh K. Agrawal
Distinguished in Invertebral Disc Disease
Dr. Subodh K. Agrawal
Interventional Cardiology | Cardiology | Sleep Medicine
Distinguished in Invertebral Disc Disease
Dr. Subodh K. Agrawal
Interventional Cardiology | Cardiology | Sleep Medicine

Athens Heart Center And Specialty Clinics

2005 Prince Ave, 
Athens,, GA 
706-208-8258
Experience:
35+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Subodh K. Agrawal, MD, FACC is an Athens, Georgia based board-certified cardiologist and healthcare entrepreneur with over three decades of clinical and leadership experience. He is the founder of Athens Heart Center and serves as CEO of Doctors ACO, where he focuses on improving care delivery, operational efficiency, and financial sustainability for medical practices across the United States.Dr. Agrawal specializes in cardiology, internal medicine, sleep medicine, and pain management, bringing a multidisciplinary approach to patient care and practice optimization. His clinical training includes fellowships at Emory University School of Medicine and the University of Alabama at Birmingham, following his MBBS from SMS Medical College, University of Rajasthan, India.In addition to his clinical work, Dr. Agrawal is actively involved in advancing healthcare innovation, including the adoption of AI-driven solutions to improve patient communication, front-desk efficiency, and revenue cycle performance in modern medical practices.Earlier in his career, he held international medical positions in Zambia, England, and Germany, contributing to diverse healthcare systems and gaining global clinical experience.Dr. Agrawal is also the founder of Physicians Circle for Patients, a nonprofit initiative dedicated to helping underserved and low-income patients access essential medical care. Dr. Agrawal is rated as a Distinguished provider by MediFind in the treatment of Invertebral Disc Disease. His top areas of expertise are Sitosterolemia, Chronic Pain, Pulmonary Edema, Hypertension, and Pacemaker Implantation.

View All Doctors
What are the latest Invertebral Disc Disease Clinical Trials?
A Prospective, Randomized, Double-Blinded, Sham-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of IDCT in Subjects With Single-Level, Symptomatic Mild to Moderate Lumbar Intervertebral Disc Degeneration
A Prospective, Randomized, Double-Blinded, Sham-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of IDCT in Subjects With Single-Level, Symptomatic Mild to Moderate Lumbar Intervertebral Disc Degeneration
Enrollment Status: Recruiting
Publish Date: February 11, 2026
Intervention Type: Biological, Other
Study Phase: Phase 3

Summary: This is a Phase III, randomized, double-blinded, Sham-controlled, multi-center study in subjects with single-level, symptomatic lumbar (L3- S1) intervertebral disc degeneration. The study will have a 52-week primary period followed by 52 week Follow-up Period (total of 104 weeks). The study protocol will be approved by the Institutional Review Board (IRB) or Independent Ethics Committee (IEC), and...

Match to trials
Find the right clinical trials for you in under a minute
Get started
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Enrollment Status: Recruiting
Publish Date: February 03, 2026
Intervention Type: Other, Device
Study Phase: Not Applicable

Summary: A multi-center, prospective, dual arm, randomized, controlled pivotal study to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL™ System.

View All Clinical Trials